| 0 (0%) | 12-03 21:56 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 29.19 | 1-year : | 34.1 |
| Resists | First : | 25 | Second : | 29.19 |
| Pivot price | 24.42  |
|||
| Supports | First : | 24.2 |
Second : | 23.7 |
| MAs | MA(5) : | 24.58 |
MA(20) : | 24.37 |
| MA(100) : | 14.06 |
MA(250) : | 0 | |
| MACD | MACD : | 1.3  |
Signal : | 1.7 |
| %K %D | K(14,3) : | 72.1 |
D(3) : | 63.4 |
| RSI | RSI(14): 80.1 | |||
| 52-week | High : | 25 | Low : | 3.18 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PRVB ] has closed Bollinger Bands are 82.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 25.02 - 25.14 | 25.14 - 25.25 |
| Low: | 24.68 - 24.82 | 24.82 - 24.93 |
| Close: | 24.78 - 24.99 | 24.99 - 25.17 |
Sat, 29 Apr 2023
Those who invested in Provention Bio (NASDAQ:PRVB) a year ago ... - Yahoo Finance
Thu, 27 Apr 2023
Breakeven On The Horizon For Provention Bio, Inc. (NASDAQ:PRVB) - Simply Wall St
Sun, 02 Apr 2023
Provention Bio, Inc. (NASDAQ:PRVB) Just Reported And Analysts ... - Yahoo Finance
Tue, 14 Mar 2023
Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi - Yahoo Finance
Mon, 13 Mar 2023
Stocks making the biggest moves midday: First Republic Bank, Moderna, Newmont, Illumina and more - CNBC
Mon, 13 Mar 2023
SGEN Stock Rockets On $43 Billion Takeover; Sanofi Buys Provention - Investor's Business Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 91 (M) |
| Held by Insiders | 6.961e+007 (%) |
| Held by Institutions | 4.6 (%) |
| Shares Short | 8,200 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.2693e+008 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -993.9 % |
| Return on Assets (ttm) | -43.1 % |
| Return on Equity (ttm) | -97.7 % |
| Qtrly Rev. Growth | 1 % |
| Gross Profit (p.s.) | 165.89 |
| Sales Per Share | 5.23984e+006 |
| EBITDA (p.s.) | -2.57805e+007 |
| Qtrly Earnings Growth | -1.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -75 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 44.2 |
| Dividend | 0 |
| Forward Dividend | 5.88e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|